Literature DB >> 7824884

Subpopulations of T lymphocytes in the peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients.

M K Ghosh1, A Nandy, M Addy, T K Maitra, A C Ghose.   

Abstract

Distribution of different subpopulations of T cells in the dermal lesions, lymph nodes and peripheral blood of post kala-azar dermal lesihmaniasis (PKADL) patients was studied by using appropriate phenotypic markers for CD2+, CD4+ and CD8+ cells. Histopathological studies of skin lesions showed marginal to massive infiltration of mononuclear cells depending upon the duration of illness and type of lesions. Thus, while the hypopigmented patches were represented by small focal collections of lymphocytes with scanty parasites in the dermis, these were replaced at the nodular stage with massive granulomas consisting of lymphocytes, plasma cells and histiocytes with numerous amastigotes. The involvement of CD4+ and CD8+ cell types in these lesions also showed a gradual change from the appearance of a few cells of both the phenotypes in early hypopigmented type to massive accumulation of cells, primarily of CD8+ phenotype, in the granuloma of nodular type. However, the observed preponderance of CD8+ cells at the lesion site of chronic PKADL patients is in contrast to their peripheral blood CD4+/CD8+ cell ratio (1.9:1) which remained within the normal limits. Similar studies of lymph nodes from PKADL patients with lymphadenopathy revealed infiltration of the cortical areas by T cells which were more of CD8+ than CD4+ phenotypes. All these results document the involvement of CD8+ cells in leishmanoid lesions. Thus, it is likely that these cells, in association with appropriate subpopulations of CD4+ cells, play a profound role in the evolution of dermal pathology in PKADL.

Entities:  

Mesh:

Year:  1995        PMID: 7824884     DOI: 10.1111/j.1365-3083.1995.tb03527.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.

Authors:  O F Osman; L Oskam; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; E E Zijlstra; P A Kager
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

4.  Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods.

Authors:  P Salotra; G Sreenivas; K R Beena; A Mukherjee; V Ramesh
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

5.  Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Authors:  H Kaushal; R Bras-Gonçalves; K Avishek; D Kumar Deep; E Petitdidier; J-L Lemesre; G Papierok; S Kumar; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

Review 6.  Cutaneous Manifestations of Human and Murine Leishmaniasis.

Authors:  Breanna M Scorza; Edgar M Carvalho; Mary E Wilson
Journal:  Int J Mol Sci       Date:  2017-06-18       Impact factor: 5.923

7.  Histopathology of Post Kala-azar Dermal Leishmaniasis.

Authors:  V Ramesh; M Ramam
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

Review 8.  Lessons from other diseases: granulomatous inflammation in leishmaniasis.

Authors:  Paul M Kaye; Lynette Beattie
Journal:  Semin Immunopathol       Date:  2015-12-17       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.